A Cagliola

509 total citations
9 papers, 392 citations indexed

About

A Cagliola is a scholar working on Surgery, Gastroenterology and Pharmacology. According to data from OpenAlex, A Cagliola has authored 9 papers receiving a total of 392 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 6 papers in Gastroenterology and 2 papers in Pharmacology. Recurrent topics in A Cagliola's work include Gastroesophageal reflux and treatments (6 papers), Helicobacter pylori-related gastroenterology studies (6 papers) and Eosinophilic Esophagitis (4 papers). A Cagliola is often cited by papers focused on Gastroesophageal reflux and treatments (6 papers), Helicobacter pylori-related gastroenterology studies (6 papers) and Eosinophilic Esophagitis (4 papers). A Cagliola collaborates with scholars based in United States, Canada and Mexico. A Cagliola's co-authors include Thomas J. Humphries, Malcolm Robinson, Thomas Simon, Malcolm M. Berenson, Basil I. Hirschowitz, Arthur J. McCullough, Barry M. Bowen, Eric Mortensen, Richard H. Hunt and Hui Quan and has published in prestigious journals such as Gastroenterology, The American Journal of Medicine and Alimentary Pharmacology & Therapeutics.

In The Last Decade

A Cagliola

9 papers receiving 369 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Cagliola United States 8 278 251 71 37 34 9 392
Bianchi Porro G Italy 10 231 0.8× 172 0.7× 40 0.6× 52 1.4× 58 1.7× 36 398
W Lucke South Africa 13 341 1.2× 162 0.6× 24 0.3× 115 3.1× 20 0.6× 22 421
Julio Argonz Cuba 8 214 0.8× 174 0.7× 43 0.6× 26 0.7× 15 0.4× 13 357
Rafael Amaro United States 9 165 0.6× 107 0.4× 46 0.6× 41 1.1× 17 0.5× 20 299
Masafumi Kusunoki Japan 12 208 0.7× 139 0.6× 38 0.5× 94 2.5× 15 0.4× 27 344
G Schmidt Australia 9 336 1.2× 168 0.7× 23 0.3× 69 1.9× 57 1.7× 18 439
Elizabeth M. Behler United States 8 269 1.0× 176 0.7× 69 1.0× 91 2.5× 6 0.2× 10 380
S Lanzon-Miller United Kingdom 10 453 1.6× 338 1.3× 17 0.2× 139 3.8× 42 1.2× 17 570
Yuji Shimada Japan 11 189 0.7× 138 0.5× 11 0.2× 34 0.9× 14 0.4× 59 357
Angelo Dezi Italy 8 197 0.7× 52 0.2× 66 0.9× 22 0.6× 5 0.1× 18 341

Countries citing papers authored by A Cagliola

Since Specialization
Citations

This map shows the geographic impact of A Cagliola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Cagliola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Cagliola more than expected).

Fields of papers citing papers by A Cagliola

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Cagliola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Cagliola. The network helps show where A Cagliola may publish in the future.

Co-authorship network of co-authors of A Cagliola

This figure shows the co-authorship network connecting the top 25 collaborators of A Cagliola. A scholar is included among the top collaborators of A Cagliola based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Cagliola. A Cagliola is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Hunt, Richard H., B.M. Bowen, Craig James, et al.. (2001). COX-2 specific inhibition with MK-0663 120 Mg Q.D. Over 4 weeks did not increase fecal blood loss: A controlled study with placebo and ibuprofen 800 Mg T.I.D.. Gastroenterology. 120(5). A597–A597. 2 indexed citations
2.
Hunt, Richard H., Barry M. Bowen, Eric Mortensen, et al.. (2000). A randomized trial measuring fecal blood loss after treatment with rofecoxib, ibuprofen, or placebo in healthy subjects. The American Journal of Medicine. 109(3). 201–206. 63 indexed citations
3.
Hanauer, S., et al.. (1997). Leukotrienes in ulcerative colitis: Results of a multicenter trial of a leukotriene biosynthesis inhibitor, MK-591. Gastroenterology. 112(3). 725–732. 61 indexed citations
4.
Simon, Thomas, Malcolm M. Berenson, Roger G. Berlin, Steven Snapinn, & A Cagliola. (1994). Randomized, placebo‐controlled comparison of famotidine 20 mg b.d. or 40 mg b.d. in patients with erosive oesophagitis. Alimentary Pharmacology & Therapeutics. 8(1). 71–79. 14 indexed citations
5.
Sontag, Stephen J., Basil I. Hirschowitz, S. Holt, et al.. (1992). Two doses of omeprazole versus placebo in symptomatic erosive esophagitis: The U.S. multicenter study. Gastroenterology. 102(1). 109–118. 137 indexed citations
6.
Graham, David Y., John H. Walsh, Arthur J. McCullough, et al.. (1992). Ulcer recurrence following duodenal ulcer healing with omeprazole, ranitidine, or placebo: A double-blind, multicenter, 6-month study. Gastroenterology. 102(4). 1289–1294. 17 indexed citations
7.
Valenzuela, Jorge E., Roger G. Berlin, Basil I. Hirschowitz, et al.. (1991). U.S. experience with omeprazole in duodenal ulcer. Digestive Diseases and Sciences. 36(6). 761–768. 33 indexed citations
8.
Robinson, Malcolm, Paul N. Maton, Melvin L. Allen, et al.. (1991). Effect of different doses of omeprazole on 24‐hour oesophageal acid exposure in patients with gastro‐oesophageal reflux. Alimentary Pharmacology & Therapeutics. 5(6). 645–651. 32 indexed citations
9.
Orr, William C., Malcolm Robinson, Thomas J. Humphries, Joseph M. Antonello, & A Cagliola. (1988). Dose—response effect of famotidine on patterns of gastro‐oesophageal reflux. Alimentary Pharmacology & Therapeutics. 2(3). 229–235. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bianchi Porro G Breakdown of academic impact, for papers by W Lucke Breakdown of academic impact, for papers by Julio Argonz Breakdown of academic impact, for papers by Rafael Amaro Breakdown of academic impact, for papers by Masafumi Kusunoki Breakdown of academic impact, for papers by G Schmidt Breakdown of academic impact, for papers by Elizabeth M. Behler Breakdown of academic impact, for papers by S Lanzon-Miller Breakdown of academic impact, for papers by Yuji Shimada Breakdown of academic impact, for papers by Angelo Dezi
Rankless by CCL
2026